Rexulti and Sunosi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rexulti (brexpiprazole) and Sunosi (solriamfetol). Common drug interactions include depression among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Rexulti and Sunosi. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Rexulti?

Rexulti has active ingredients of brexpiprazole. It is often used in major depression. eHealthMe is studying from 13,394 Rexulti users. Check the latest studies of Rexulti.

What is Sunosi?

Sunosi has active ingredients of solriamfetol. eHealthMe is studying from 2,936 Sunosi users. Check the latest studies of Sunosi.



On Jul, 05, 2026

38 people who take Rexulti and Sunosi together, and have interactions are studied.

Rexulti and Sunosi drug interactions.

What are the common drug interactions of Rexulti and Sunosi, by gender? *:

female:

  1. Depression
  2. Fatigue (feeling of tiredness)
  3. Blood glucose fluctuation
  4. Dyspnoea (difficult or laboured respiration)
  5. Nausea (feeling of having an urge to vomit)
  6. Nocturia (the need to get up in the night to urinate)
  7. Obesity (having too much body fat)
  8. Osteoporosis (bones weak and more likely to break)
  9. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  10. Tardive dyskinesia (a disorder that involves involuntary movements)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Mood altered (changes in mood)
  3. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  4. Suicidal ideation
  5. Tremor (trembling or shaking movements in one or more parts of your body)
  6. Blood glucose increased
  7. Confusional state
  8. Encephalopathy (functioning of the brain is affected by some agent or condition)
  9. Lung disorder (lung disease)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

What are the common drug interactions of Rexulti and Sunosi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Depression
  3. Hospitalisation
  4. Borderline personality disorder
  5. Suicidal ideation

30-39:

  1. Confusional state
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Lung disorder (lung disease)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Surgery

40-49:

  1. Bradycardia (abnormally slow heart action)
  2. Cardiac disorder
  3. Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
  4. Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
  5. Stress cardiomyopathy (stress-induced chronic disease of the heart muscle)

50-59:

  1. Blood glucose fluctuation
  2. Depression
  3. Immobile (not moving)
  4. Neurosurgery
  5. Fall
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Arthropathy
  8. Food craving
  9. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  10. Dyspnoea (difficult or laboured respiration)

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 34 people, 89.47%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 18 people, 47.37%
  3. Drowsiness: 11 people, 28.95%
  4. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 4 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Rexulti and Sunosi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rexulti and Sunosi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rexulti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sunosi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rexulti and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sunosi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on brexpiprazole and solriamfetol (the active ingredients of Rexulti and Sunosi, respectively), and Rexulti and Sunosi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: